Addiction Medicine
Feature
Largest-ever study into the effects of cannabis on the brain
“The study wants to bring the two sides of the argument together and understand what’s really happening.”
From the Journals
Psychiatrists’ views on psychoactive drugs clash with U.S. policy
Survey respondents viewed psilocybin and ketamine as similarly safe – and safer than methamphetamine and alprazolam.
Latest News
DOJ: Indiana nurses allowed controlled substances during opioid recovery
“This improvement will increase access to treatment resources, enabling more nurses to complete treatment and progress toward a safe return to...
From the Journals
Alcohol warning labels need updates to reflect harms: NEJM
The current warning is“so understated that it borders on being misleading.”
Evidence-Based Reviews
Laboratory monitoring for patients on buprenorphine: 10 questions
How to best use laboratory testing for patients with opioid use disorder.
From the Journals
Stable, long-term opioid therapy safer than tapering?
The investigators compared three dosing strategies: abrupt withdrawal, gradual tapering, and continuation of the current stable dosage.
Commentary
TikTok’s impact on adolescent mental health
Hateful speech such as racism, sexism, or xenophobia can accumulate on TikTok, which may cause more self-harm than self-help.
From the Journals
Psychedelic drug therapy a potential ‘breakthrough’ for alcohol dependence
The effects observed with psilocybin were “considerably larger” than those of currently approved treatments for alcohol use disorder.
From the Journals
Brief Psychiatric Rating Scale succeeds as transdiagnostic measure
The BPRS showed solid correlation with the mini-ICF-APP for disorders in six different categories.
Latest News
Patients who engage in risky ‘chemsex’ benefit from appropriate treatment
Chemsex combines sex, drugs, and smartphones, and physicians know very little about it.
From the Journals
‘Shocking’ and persistent gap in treatment for opioid addiction
In all 50 states and Washington, D.C., past-year prevalence of opioid use disorder was greater than rates of medication use.